NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.06 +0.06 (+0.08%) GOLD FUTURES
2,330.90 +19.90 (+0.86%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,137.15 -2,072.51 (-4.30%)
NTRA Jul 2024 40.000 call
| Previous close | 21.19 |
| Open | 21.17 |
| Bid | 22.30 |
| Ask | 26.90 |
| Strike | 40.00 |
| Expiry date | 2024-07-19 |
| Day's range | 21.17 - 21.79 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
Business WireNatera to Report its First Quarter 2024 Results on May 9
AUSTIN, Texas, May 01, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its first quarter ended March 31, 2024, after the market close on May 9, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).
Business WireNatera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
AUSTIN, Texas, May 01, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of a new cfDNA-based fetal RhD test. This comes at a critical time for the healthcare industry, helping physicians navigate patient care given nationwide shortages of Rho(D) immune globulin therapy (RhIg).
GuruFocus.comInsider Sell: CFO Michael Brophy Sells Shares of Natera Inc
Natera Inc (NASDAQ:NTRA), a leader in personalized genetic testing and diagnostics, has seen a recent insider transaction according to the latest SEC Filing.
